{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:02:15Z","timestamp":1791216135712,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"crossref","award":["6-2008-0227"],"award-info":[{"award-number":["6-2008-0227"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbrc.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T03:42:17Z","timestamp":1308541337000},"page":"581-586","source":"Crossref","is-referenced-by-count":98,"title":["Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-\u03baB acetylation in fibroblast-like synoviocyte MH7A cells"],"prefix":"10.1016","volume":"410","author":[{"given":"Ah-Reum","family":"Seong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyungChul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunoh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Geun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.06.029_b0005","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1128\/MCB.25.18.7966-7975.2005","article-title":"NF-kappaB RelA phosphorylation regulates RelA acetylation","volume":"25","author":"Chen","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2011.06.029_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1329.002","article-title":"A beginner\u2019s guide to NF-kappaB signaling pathways","volume":"1030","author":"Delhalle","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2011.06.029_b0015","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2011.06.029_b0020","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-kappaB action regulated by reversible acetylation","volume":"293","author":"Chen","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2011.06.029_b0025","article-title":"Inhibition of NF-kappaB signaling as a strategy in disease therapy","author":"Gilmore","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbrc.2011.06.029_b0030","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.029_b0035","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.06.029_b0040","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","article-title":"Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation","volume":"580","author":"Sun","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2011.06.029_b0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/0008-5472.CAN-08-2442","article-title":"Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation","volume":"69","author":"Choi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.06.029_b0050","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1158\/1541-7786.MCR-09-0239","article-title":"Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells","volume":"7","author":"Choi","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2011.06.029_b0055","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/emboj\/cdg120","article-title":"Purification functional characterization of the human N-CoR complex: the roles of HDAC3 TBL1 and TBLR1","volume":"22","author":"Yoon","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2011.06.029_b0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/jf0108765","article-title":"Antioxidant activities of pomegranate fruit extract its anthocyanidins: delphinidin, cyanidin, and pelargonidin","volume":"50","author":"Noda","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2011.06.029_b0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00296-006-0109-4","article-title":"Enhancement of anti-inflammatory tendency by SB203580, p38alpha specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A","volume":"26","author":"Han","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbrc.2011.06.029_b0070","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/carcin\/bgp216","article-title":"Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase","volume":"30","author":"Kwon","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2011.06.029_b0075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bcp.2008.12.021","article-title":"Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha","volume":"77","author":"Hwang","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.029_b0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-002-0553-y","article-title":"Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity","volume":"365","author":"Garbacki","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.06.029_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2011.06.029_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1566524013363537","article-title":"Histone acetylation\/deacetylation and cancer: an \u201copen\u201d and \u201cshut\u201d case?","volume":"1","author":"Gray","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bbrc.2011.06.029_b0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2011.06.029_b0100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T00:21:15Z","timestamp":1543710075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11009879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006291X11009879"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.029","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}